Regulus Therapeutics Inc (NASDAQ:RGLS)

0.7002
Delayed Data
As of May 22
 -0.0048 / -0.68%
Today’s Change
0.63
Today|||52-Week Range
1.60
-32.67%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$74.8M

Company Description

Regulus Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and development of drugs targeting microRNAs. The company was founded in September 2007 and is headquartered in San Diego, CA.

Contact Information

Regulus Therapeutics, Inc.
10614 Science Center Drive
San Diego California 92121
P:(888) 734-8587
Investor Relations:

Employees

Shareholders

Individual stakeholders42.02%
Other institutional24.67%
Mutual fund holders17.05%

Top Executives

Joseph P. HaganPresident, CEO, COO & Director
Daniel R. ChevallardChief Financial & Accounting Officer
Timothy M. WrightChief Research & Development Officer
Mark DeegChief Medical Officer
Michael HuangVice President-Clinical Development